Meng-Yu Wang Selected Research

LTX-315

1/2019	Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model.
1/2017	Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meng-Yu Wang Research Topics

Disease

2	Fatty Liver 01/2022 - 01/2022
2	Neoplasms (Cancer) 01/2019 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 01/2009
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Obesity 01/2022
1	Mental Disorders (Mental Disorder) 10/2021
1	Ganglion Cysts (Ganglion) 01/2020
1	Insulin Resistance 12/2019
1	Parkinsonian Disorders (Parkinsonism) 11/2019
1	False Aneurysm (Pseudoaneurysm) 05/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Fibrosarcoma 01/2017
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2016
1	Stroke (Strokes) 10/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2011
1	Carcinoma (Carcinomatosis) 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

2	LTX-315IBA 01/2019 - 01/2017
2	Peptides (Polypeptides)IBA 01/2019 - 01/2017
1	16S Ribosomal RNAIBA 01/2022
1	AmmoniaIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 12/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2019
1	parkin proteinIBA 11/2019
1	AlarminsIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Oxygen (Dioxygen)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2016
1	SCR-4026IBA 10/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 10/2016
1	N-Methylaspartate (NMDA)IBA 10/2016
1	Phosphotransferases (Kinase)IBA 01/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2009
1	AndrogensIBA 01/2009
1	Conditioned Culture MediaIBA 01/2009

Therapy/Procedure

2	Immunotherapy 01/2019 - 01/2017
1	Moxibustion 10/2021
1	Acupuncture Points (Acupuncture Point) 10/2021
1	Stents 05/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Stem Cell Transplantation 01/2011